Andrea Callegaro

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

Brigitte Dréno, John F Thompson, B. Mark Smithers et al. · The Lancet Oncology · 2018 · 198 citations · Full text

Medicine, Immunology, Oncology +14

Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans

Wivine Burny, Andrea Callegaro, Viviane Bechtold et al. · Frontiers in Immunology · 2017 · 153 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

A gene expression signature associated with survival in metastatic melanoma

Susanna Mandruzzato, Andrea Callegaro, Gianluca Turcatel et al. · Journal of Translational Medicine · 2006 · 112 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans

Wivine Burny, Arnaud Marchant, Caroline Hervé et al. · Vaccine · 2019 · 76 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Transcriptional profiles of adjuvanted hepatitis B vaccines display variable interindividual homogeneity but a shared core signature

Laurane De Mot, Viviane Bechtold, Vanesa Bol et al. · Science Translational Medicine · 2020 · 67 citations

Life Sciences, Immunology, Infectious Diseases +17